6Chalker V, Stocki T, Mentasti M, et al. Increased incidence of Mycoplasma pneumoniae infection in England and Wales in 2010: muhiocus variable number tandem repeat analysis typing and macrolide susceptibility[ J]. Euro Surveill, 2011, 16 (19) : pii 19865.
7Sur G, Kudor-Szabadi L, Vidrean V, et al. Etiology of pneumonia in children in the absence of pneumococcal and antihaemophilus vaccines[J]. Roum Arch Microbiol Immunol, 2012, 71 (1): 48 -52.
8Xin D, Mi Z, Han X, et al. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China [ J ]. Antimicrob Agents Chemother, 2009, 53 (5) : 2158 - 2159.
9Zhao F, Liu G, Wu J, et al. Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012[ J]. Antimicrob Agents Chenmother, 2013, 57(3) : 1521 -1523.
10Cao B, Zhao CJ, Yin YD, et al. High prevalence of maerolide resistance in Mycoplasma pneumoniae isolates from adult and adoles- cent patients with respiratory tract infection in China[ J]. Clin Infect Dis, 2010, 51(2): 189-194.
